Aspect Biosystems
Vancouver
About Aspect Biosystems
Aspect Biosystems is a biotechnology company developing bioprinted tissue therapeutics to transform how we treat disease. By combining its proprietary microfluidic 3D bioprinting technology, therapeutic cells, and materials science, Aspect is creating a pipeline of allogeneic cell-based tissue therapeutics to replace or repair damaged organ functions. The company is also partnering with leading researchers and industry innovators worldwide to tackle the biggest challenges in regenerative medicine.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $252.8M
- Funding stage: Early Stage Venture
- Last round: Grant (Apr 2026)
- Website: aspectbiosystems.com
- Phone: 604-263-0502
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/aspect-biosystems-102307 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.